[Industry Trends]
In the fields of infant products and food-grade seals, a breakthrough material is drawing industry attention—the newly launched IOTA LSR 3040 series liquid silicone rubber. With its secondary vulcanization-free process and exceptional grip performance, it offers manufacturers a more efficient and safer solution.

[Key Highlights]
The material features a two-component 1:1 mixing design, eliminating the need for traditional secondary vulcanization and significantly shortening the production cycle. For instance, with high-temperature curing at 130°C, molding is completed in just 90 seconds, improving efficiency by over 80% compared to traditional processes. Its mechanical properties are particularly outstanding: tensile strength reaches 9 MPa, elongation is as high as 580%, and it can withstand repeated deformation without breaking, making it ideal for dynamic sealing applications.

[Safety Certifications]
The product has obtained multiple international certifications, including BfR, FDA, and ROHS, with VOC emissions below 0.5%, meeting stringent standards for infant products and food-contact materials. Experimental data shows that at a thickness of 2 mm, high-temperature curing at 150°C requires only 45 seconds, and the post-curing density remains stable at 1.11 g/cm³, ensuring no deformation risk during long-term use.

[Application Scenarios]
Currently, the material has been successfully applied in areas such as baby nipples, food-grade sealing rings, and medical catheters. Tests by a renowned maternal and infant brand indicate that nipples produced with this material have an extended temperature resistance range of -40°C to 230°C and maintain structural integrity even after 100,000 folding tests.

[Expert Reminder]
Technicians specifically note that due to the inclusion of platinum catalysts, strict measures to avoid light and moisture are required during operation. Specialized mixing equipment is recommended to ensure component uniformity. The first batch of mass-produced products has passed third-party aging tests and is expected to be fully launched into the market this quarter.